Updated and Expanded Breast Cancer Overview
Treating more breast cancer patients than any other cancer center in the nation, Memorial Sloan-Kettering provides comprehensive, multidisciplinary care to breast cancer patients, including a full array of supportive services such as nutritional and genetic counseling, gynecologic and endocrinological care, physical therapy, and the most extensive psychosocial support programs in the region. In this newly updated and expanded section, you can find information about our expertise in treating patients with breast cancer, our services, and our research.
Updated Cervical Cancer Overview
Memorial Sloan-Kettering Cancer Center's team of doctors, nurses, and other healthcare professionals who treat cervical cancer are dedicated to providing the highest quality of screening, counseling, and care for women with this disease. These newly revised cervical cancer pages include information about risk factors and prevention, screening and surveillance, symptoms, diagnosis, treatment, and survivorship and support.
Monoclonal Antibody Drugs for Cancer Treatment
The strategy of using monoclonal antibodies for cancer treatment was first described in the late 1970s with the promise that they could be developed into therapies that were highly specific to cancer cells, killing them with few or no side effects. For several types of cancer, monoclonal antibodies have already offered this advantage to patients. For other cancer types, they have provided an additional therapeutic weapon, but with smaller benefits and sometimes new side effects.
Researchers Create Smaller, Brighter Probe, Tailored for Clinical Molecular Imaging and Tumor Targeting
Researchers at Memorial Sloan-Kettering and Cornell University have developed a new generation of microscopic particles for molecular imaging, constituting one of the first promising nanoparticle platforms that may be readily adapted for tumor targeting and treatment in the clinic.
Investigators Discover Technique to Restore and Enhance Intestinal Immune Defense
Infection by antibiotic-resistant bacteria is a dangerous complication of broad-spectrum antibiotic therapy. Treatment with antibiotics impairs natural immune defenses in the intestines, allowing antibiotic-resistant microbes to flourish. Now Memorial Sloan-Kettering researchers have found a way to restore innate immune defense in the intestines and enhance resistance to vancomycin-resistant Enterococcus (VRE), a potentially harmful antibiotic-resistant bacterium.
Radiochemist Jason Lewis
Sloan-Kettering Institute radiochemist Jason Lewis is working to develop new PET radiopharmaceuticals for the diagnosis and treatment of cancer.
How We Care for Our Patients Video
An online video describing Memorial Sloan-Kettering's unique approach to treating individuals with cancer, in which compassion and innovative treatments are combined to provide the best chance for a positive outcome.
Breast Cancer Medicine, Present and Future: An Interactive Lecture
On Thursday, March 26, Larry Norton, Deputy Physician-in-Chief for Breast Cancer Programs, discusses the latest developments in the screening and treatment of breast cancer.
The Latest in Skin Cancer: Detection, Diagnosis, and Treatment
On Tuesday, April 14, our experts discuss the up-to-date information on screening and treatment of skin cancer.
End of Life Issues: The Important Role of Palliative Care and Counseling
On Thursday, April 30, our experts provide an overview of pain management and palliative care for people with cancer and their families.
